SPONSOR
OHSU Knight Cancer Institute
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: Pancreatic CarcinomaHematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmStage I Pancreatic Cancer AJCC v8Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Mantle Cell LymphomaLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Pancreatic Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Stage I Pancreatic Cancer AJCC v8.
The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — OHSU Knight Cancer Institute
How many clinical trials has OHSU Knight Cancer Institute sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by OHSU Knight Cancer Institute, of which 5 are actively recruiting participants. These trials cover conditions including Pancreatic Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does OHSU Knight Cancer Institute research focus on?
OHSU Knight Cancer Institute clinical trials span Pancreatic Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a OHSU Knight Cancer Institute clinical trial?
To participate in a OHSU Knight Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all OHSU Knight Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by OHSU Knight Cancer Institute
NCT06084013
Recruiting
Use Of Indocyanine Green In Pancreas Surgery
Pancreatic Carcinoma
NCT06342453
Recruiting
CREATE: Art for Children With Cancer
Hematopoietic and Lymphatic System Neoplasm
NCT07651358
Recruiting
A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
Stage I Pancreatic Cancer AJCC v8
NCT06357676 Phase 1, Phase 2
Recruiting
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial
Mantle Cell Lymphoma
NCT04005690 EARLY_Phase 1
Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Locally Advanced Pancreatic Ductal Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology